This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Genfit. Active years: 2015-2020.
Company Filing History:
Years Active: 2015-2020
Title: The Innovative Contributions of Mathieu Dubernet
Introduction
Mathieu Dubernet is a notable inventor based in Santes, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on triazolopyridazines. With a total of 3 patents to his name, Dubernet continues to push the boundaries of scientific research and development.
Latest Patents
Dubernet's latest patents include the development of derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists. These novel compounds are designed to activate Rev-Erb, which has therapeutic effects in treating various diseases. The pharmaceutical compositions derived from these compounds are particularly suitable for addressing inflammatory and circadian rhythm-related disorders, as well as cardiometabolic diseases.
Career Highlights
Mathieu Dubernet is currently associated with Genfit, a company that focuses on developing innovative therapeutic solutions. His work at Genfit has allowed him to explore the potential of his inventions in real-world applications, contributing to advancements in medical science.
Collaborations
Dubernet collaborates with esteemed colleagues such as Jean-Francois Delhomel and Maryline Bourotte. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Mathieu Dubernet's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for new therapeutic solutions that can significantly impact healthcare.